Anisha B. Patel

Orthopedics
2160 S 1st Ave
Maywood, IL 60153

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications

IGF1 modulates lesional skin inflammation in checkpoint inhibitor-induced lichen planus.

IGF1 modulates lesional skin inflammation in checkpoint inhibitor-induced lichen planus.

Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026

Rare irAEs associated with immune checkpoint inhibitor therapy.

Rare irAEs associated with immune checkpoint inhibitor therapy.

Journal: Expert opinion on drug safety
Published: February 10, 2026

Epidermal Growth Factor Receptor Inhibitor Use and Postoperative Outcomes Following Mohs Micrographic Surgery.

Epidermal Growth Factor Receptor Inhibitor Use and Postoperative Outcomes Following Mohs Micrographic Surgery.

Journal: International journal of dermatology
Published: January 18, 2026

Postoperative Outcomes in Dermatologic Surgery Among Patients Receiving VEGF and VEGFR Inhibitors: A Propensity-Matched Real-World Analysis.

Postoperative Outcomes in Dermatologic Surgery Among Patients Receiving VEGF and VEGFR Inhibitors: A Propensity-Matched Real-World Analysis.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: January 07, 2026

Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele.

Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele.

Journal: Cancer
Published: September 05, 2025

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors.

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors.

Journal: Journal for immunotherapy of cancer
Published: July 16, 2025

Cutaneous toxicities secondary to STAT3 inhibition: A retrospective case series.

Cutaneous toxicities secondary to STAT3 inhibition: A retrospective case series.

Journal: JAAD case reports
Published: July 03, 2025

Cutaneous adverse effects of combination epidermal growth factor receptor inhibitor and immune checkpoint inhibitor cancer therapy.

Cutaneous adverse effects of combination epidermal growth factor receptor inhibitor and immune checkpoint inhibitor cancer therapy.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 11, 2025

Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance.

Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 04, 2025

A retrospective case series of eight patients with epidermal growth factor receptor inhibitor-induced cutaneous toxicities managed with dupilumab.

A retrospective case series of eight patients with epidermal growth factor receptor inhibitor-induced cutaneous toxicities managed with dupilumab.

Journal: JAAD case reports
Published: November 25, 2024

Cutaneous lupus erythematosus presenting as a nonhealing ulcer in an African American woman: A case report.

Cutaneous lupus erythematosus presenting as a nonhealing ulcer in an African American woman: A case report.

Journal: American journal of clinical pathology
Published: October 10, 2024

Cutaneous Surgery Outcomes in Patients on Vascular Endothelial Growth Factor Receptor Inhibitors.

Cutaneous Surgery Outcomes in Patients on Vascular Endothelial Growth Factor Receptor Inhibitors.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: October 03, 2024
Showing 1-12 of 95

Last Updated: 09/26/2026